Chabu Lab tumor-targeting bacteria technology receives U.S. patent
June 9, 2026The United States Patent and Trademark Office has issued U.S. Patent No. 12,648,970, "Compositions and Methods of Treatment Comprising Tumor-Targeting Bacteria and Chemotherapy or Immunotherapy Agent”. Congratulations to the team. The patented technology underpins the lab's engineered bacterial therapeutics program, which uses tumor-colonizing bacteria to deliver immunomodulatory payloads directly into...